8-[5-(3,5-dimethylpyrazin-2-yl)-1-(4-methylphenyl)pyrazole-3-carbonyl]-1-(4-methylphenyl)-1,8-diazaspiro[4.5]decan-4-one;1-(4-methylphenyl)-8-[1-(4-methylphenyl)-5-pyridin-3-ylpyrazole-3-carbonyl]-1,8-diazaspiro[4.5]decan-4-one;bis(1-(4-methylphenyl)-8-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]-1,3,8-triazaspiro[4.5]decan-4-one);3-[1-(1-phenyl-5-pyridin-4-ylpyrazole-3-carbonyl)piperidin-4-yl]-1H-benzimidazol-2-one

C150H143F6N29O10 — CID 158357669

IUPAC8-[5-(3,5-dimethylpyrazin-2-yl)-1-(4-methylphenyl)pyrazole-3-carbonyl]-1-(4-methylphenyl)-1,8-diazaspiro[4.5]decan-4-one;1-(4-methylphenyl)-8-[1-(4-methylphenyl)-5-pyridin-3-ylpyrazole-3-carbonyl]-1,8-diazaspiro[4.5]decan-4-one;bis(1-(4-methylphenyl)-8-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]-1,3,8-triazaspiro[4.5]decan-4-one);3-[1-(1-phenyl-5-pyridin-4-ylpyrazole-3-carbonyl)piperidin-4-yl]-1H-benzimidazol-2-one
SMILESCc1ccc(N2CCC(=O)C23CCN(C(=O)c2cc(-c4cccnc4)n(-c4ccc(C)cc4)n2)CC3)cc1.Cc1ccc(N2CCC(=O)C23CCN(C(=O)c2cc(-c4ncc(C)nc4C)n(-c4ccc(C)cc4)n2)CC3)cc1.Cc1ccc(N2CNC(=O)C23CCN(C(=O)c2cc(-c4ccncc4)n(-c4ccc(C(F)(F)F)cc4)n2)CC3)cc1.Cc1ccc(N2CNC(=O)C23CCN(C(=O)c2cc(-c4ccncc4)n(-c4ccc(C(F)(F)F)cc4)n2)CC3)cc1.O=C(c1cc(-c2ccncc2)n(-c2ccccc2)n1)N1CCC(n2c(=O)[nH]c3ccccc32)CC1
InChIInChI=1S/C32H34N6O2.C31H31N5O2.2C30H27F3N6O2.C27H24N6O2/c1-21-5-9-25(10-6-21)37-16-13-29(39)32(37)14-17-36(18-15-32)31(40)27-19-28(30-24(4)34-23(3)20-33-30)38(35-27)26-11-7-22(2)8-12-26;1-22-5-9-25(10-6-22)35-17-13-29(37)31(35)14-18-34(19-15-31)30(38)27-20-28(24-4-3-16-32-21-24)36(33-27)26-11-7-23(2)8-12-26;2*1-20-2-6-23(7-3-20)38-19-35-28(41)29(38)12-16-37(17-13-29)27(40)25-18-26(21-10-14-34-15-11-21)39(36-25)24-8-4-22(5-9-24)30(31,32)33;34-26(31-16-12-20(13-17-31)32-24-9-5-4-8-22(24)29-27(32)35)23-18-25(19-10-14-28-15-11-19)33(30-23)21-6-2-1-3-7-21/h5-12,19-20H,13-18H2,1-4H3;3-12,16,20-21H,13-15,17-19H2,1-2H3;2*2-11,14-15,18H,12-13,16-17,19H2,1H3,(H,35,41);1-11,14-15,18,20H,12-13,16-17H2,(H,29,35)
InChIKeyGTBRNILHWFBMIZ-UHFFFAOYSA-N
MW2625.97 g/mol
LogP23.74
Rot. Bonds20

About 8-[5-(3,5-dimethylpyrazin-2-yl)-1-(4-methylphenyl)pyrazole-3-carbonyl]-1-(4-methylphenyl)-1,8-diazaspiro[4.5]decan-4-one;1-(4-methylphenyl)-8-[1-(4-methylphenyl)-5-pyridin-3-ylpyrazole-3-carbonyl]-1,8-diazaspiro[4.5]decan-4-one;bis(1-(4-methylphenyl)-8-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]-1,3,8-triazaspiro[4.5]decan-4-one);3-[1-(1-phenyl-5-pyridin-4-ylpyrazole-3-carbonyl)piperidin-4-yl]-1H-benzimidazol-2-one

8-[5-(3,5-dimethylpyrazin-2-yl)-1-(4-methylphenyl)pyrazole-3-carbonyl]-1-(4-methylphenyl)-1,8-diazaspiro[4.5]decan-4-one;1-(4-methylphenyl)-8-[1-(4-methylphenyl)-5-pyridin-3-ylpyrazole-3-carbonyl]-1,8-diazaspiro[4.5]decan-4-one;bis(1-(4-methylphenyl)-8-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]-1,3,8-triazaspiro[4.5]decan-4-one);3-[1-(1-phenyl-5-pyridin-4-ylpyrazole-3-carbonyl)piperidin-4-yl]-1H-benzimidazol-2-one (PubChem CID 158357669) has the molecular formula C150H143F6N29O10 and a molecular weight of 2625.97 g/mol. Its IUPAC name is 8-[5-(3,5-dimethylpyrazin-2-yl)-1-(4-methylphenyl)pyrazole-3-carbonyl]-1-(4-methylphenyl)-1,8-diazaspiro[4.5]decan-4-one;1-(4-methylphenyl)-8-[1-(4-methylphenyl)-5-pyridin-3-ylpyrazole-3-carbonyl]-1,8-diazaspiro[4.5]decan-4-one;bis(1-(4-methylphenyl)-8-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]-1,3,8-triazaspiro[4.5]decan-4-one);3-[1-(1-phenyl-5-pyridin-4-ylpyrazole-3-carbonyl)piperidin-4-yl]-1H-benzimidazol-2-one.

Molecular Properties

Compound Name8-[5-(3,5-dimethylpyrazin-2-yl)-1-(4-methylphenyl)pyrazole-3-carbonyl]-1-(4-methylphenyl)-1,8-diazaspiro[4.5]decan-4-one;1-(4-methylphenyl)-8-[1-(4-methylphenyl)-5-pyridin-3-ylpyrazole-3-carbonyl]-1,8-diazaspiro[4.5]decan-4-one;bis(1-(4-methylphenyl)-8-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]-1,3,8-triazaspiro[4.5]decan-4-one);3-[1-(1-phenyl-5-pyridin-4-ylpyrazole-3-carbonyl)piperidin-4-yl]-1H-benzimidazol-2-one
PubChem CID158357669
Molecular FormulaC150H143F6N29O10
Molecular Weight2625.97 g/mol
Exact Mass2624.15
IUPAC Name8-[5-(3,5-dimethylpyrazin-2-yl)-1-(4-methylphenyl)pyrazole-3-carbonyl]-1-(4-methylphenyl)-1,8-diazaspiro[4.5]decan-4-one;1-(4-methylphenyl)-8-[1-(4-methylphenyl)-5-pyridin-3-ylpyrazole-3-carbonyl]-1,8-diazaspiro[4.5]decan-4-one;bis(1-(4-methylphenyl)-8-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]-1,3,8-triazaspiro[4.5]decan-4-one);3-[1-(1-phenyl-5-pyridin-4-ylpyrazole-3-carbonyl)piperidin-4-yl]-1H-benzimidazol-2-one
SMILESCc1ccc(N2CCC(=O)C23CCN(C(=O)c2cc(-c4cccnc4)n(-c4ccc(C)cc4)n2)CC3)cc1.Cc1ccc(N2CCC(=O)C23CCN(C(=O)c2cc(-c4ncc(C)nc4C)n(-c4ccc(C)cc4)n2)CC3)cc1.Cc1ccc(N2CNC(=O)C23CCN(C(=O)c2cc(-c4ccncc4)n(-c4ccc(C(F)(F)F)cc4)n2)CC3)cc1.Cc1ccc(N2CNC(=O)C23CCN(C(=O)c2cc(-c4ccncc4)n(-c4ccc(C(F)(F)F)cc4)n2)CC3)cc1.O=C(c1cc(-c2ccncc2)n(-c2ccccc2)n1)N1CCC(n2c(=O)[nH]c3ccccc32)CC1
InChIInChI=1S/C32H34N6O2.C31H31N5O2.2C30H27F3N6O2.C27H24N6O2/c1-21-5-9-25(10-6-21)37-16-13-29(39)32(37)14-17-36(18-15-32)31(40)27-19-28(30-24(4)34-23(3)20-33-30)38(35-27)26-11-7-22(2)8-12-26;1-22-5-9-25(10-6-22)35-17-13-29(37)31(35)14-18-34(19-15-31)30(38)27-20-28(24-4-3-16-32-21-24)36(33-27)26-11-7-23(2)8-12-26;2*1-20-2-6-23(7-3-20)38-19-35-28(41)29(38)12-16-37(17-13-29)27(40)25-18-26(21-10-14-34-15-11-21)39(36-25)24-8-4-22(5-9-24)30(31,32)33;34-26(31-16-12-20(13-17-31)32-24-9-5-4-8-22(24)29-27(32)35)23-18-25(19-10-14-28-15-11-19)33(30-23)21-6-2-1-3-7-21/h5-12,19-20H,13-18H2,1-4H3;3-12,16,20-21H,13-15,17-19H2,1-2H3;2*2-11,14-15,18H,12-13,16-17,19H2,1H3,(H,35,41);1-11,14-15,18,20H,12-13,16-17H2,(H,29,35)
InChIKeyGTBRNILHWFBMIZ-UHFFFAOYSA-N
XLogP23.74
TPSA411.08 Ų
H-Bond Donors3
H-Bond Acceptors31
Rotatable Bonds20
Heavy Atoms195
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002625.97
LogP ≤ 523.74
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1031

Analyze 8-[5-(3,5-dimethylpyrazin-2-yl)-1-(4-methylphenyl)pyrazole-3-carbonyl]-1-(4-methylphenyl)-1,8-diazaspiro[4.5]decan-4-one;1-(4-methylphenyl)-8-[1-(4-methylphenyl)-5-pyridin-3-ylpyrazole-3-carbonyl]-1,8-diazaspiro[4.5]decan-4-one;bis(1-(4-methylphenyl)-8-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]-1,3,8-triazaspiro[4.5]decan-4-one);3-[1-(1-phenyl-5-pyridin-4-ylpyrazole-3-carbonyl)piperidin-4-yl]-1H-benzimidazol-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 8-[5-(3,5-dimethylpyrazin-2-yl)-1-(4-methylphenyl)pyrazole-3-carbonyl]-1-(4-methylphenyl)-1,8-diazaspiro[4.5]decan-4-one;1-(4-methylphenyl)-8-[1-(4-methylphenyl)-5-pyridin-3-ylpyrazole-3-carbonyl]-1,8-diazaspiro[4.5]decan-4-one;bis(1-(4-methylphenyl)-8-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]-1,3,8-triazaspiro[4.5]decan-4-one);3-[1-(1-phenyl-5-pyridin-4-ylpyrazole-3-carbonyl)piperidin-4-yl]-1H-benzimidazol-2-one?
The IUPAC name of 8-[5-(3,5-dimethylpyrazin-2-yl)-1-(4-methylphenyl)pyrazole-3-carbonyl]-1-(4-methylphenyl)-1,8-diazaspiro[4.5]decan-4-one;1-(4-methylphenyl)-8-[1-(4-methylphenyl)-5-pyridin-3-ylpyrazole-3-carbonyl]-1,8-diazaspiro[4.5]decan-4-one;bis(1-(4-methylphenyl)-8-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]-1,3,8-triazaspiro[4.5]decan-4-one);3-[1-(1-phenyl-5-pyridin-4-ylpyrazole-3-carbonyl)piperidin-4-yl]-1H-benzimidazol-2-one (CID 158357669) is 8-[5-(3,5-dimethylpyrazin-2-yl)-1-(4-methylphenyl)pyrazole-3-carbonyl]-1-(4-methylphenyl)-1,8-diazaspiro[4.5]decan-4-one;1-(4-methylphenyl)-8-[1-(4-methylphenyl)-5-pyridin-3-ylpyrazole-3-carbonyl]-1,8-diazaspiro[4.5]decan-4-one;bis(1-(4-methylphenyl)-8-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]-1,3,8-triazaspiro[4.5]decan-4-one);3-[1-(1-phenyl-5-pyridin-4-ylpyrazole-3-carbonyl)piperidin-4-yl]-1H-benzimidazol-2-one.
What is the SMILES notation for 8-[5-(3,5-dimethylpyrazin-2-yl)-1-(4-methylphenyl)pyrazole-3-carbonyl]-1-(4-methylphenyl)-1,8-diazaspiro[4.5]decan-4-one;1-(4-methylphenyl)-8-[1-(4-methylphenyl)-5-pyridin-3-ylpyrazole-3-carbonyl]-1,8-diazaspiro[4.5]decan-4-one;bis(1-(4-methylphenyl)-8-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]-1,3,8-triazaspiro[4.5]decan-4-one);3-[1-(1-phenyl-5-pyridin-4-ylpyrazole-3-carbonyl)piperidin-4-yl]-1H-benzimidazol-2-one?
The canonical SMILES for 8-[5-(3,5-dimethylpyrazin-2-yl)-1-(4-methylphenyl)pyrazole-3-carbonyl]-1-(4-methylphenyl)-1,8-diazaspiro[4.5]decan-4-one;1-(4-methylphenyl)-8-[1-(4-methylphenyl)-5-pyridin-3-ylpyrazole-3-carbonyl]-1,8-diazaspiro[4.5]decan-4-one;bis(1-(4-methylphenyl)-8-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]-1,3,8-triazaspiro[4.5]decan-4-one);3-[1-(1-phenyl-5-pyridin-4-ylpyrazole-3-carbonyl)piperidin-4-yl]-1H-benzimidazol-2-one is Cc1ccc(N2CCC(=O)C23CCN(C(=O)c2cc(-c4cccnc4)n(-c4ccc(C)cc4)n2)CC3)cc1.Cc1ccc(N2CCC(=O)C23CCN(C(=O)c2cc(-c4ncc(C)nc4C)n(-c4ccc(C)cc4)n2)CC3)cc1.Cc1ccc(N2CNC(=O)C23CCN(C(=O)c2cc(-c4ccncc4)n(-c4ccc(C(F)(F)F)cc4)n2)CC3)cc1.Cc1ccc(N2CNC(=O)C23CCN(C(=O)c2cc(-c4ccncc4)n(-c4ccc(C(F)(F)F)cc4)n2)CC3)cc1.O=C(c1cc(-c2ccncc2)n(-c2ccccc2)n1)N1CCC(n2c(=O)[nH]c3ccccc32)CC1.
What is the InChIKey of 8-[5-(3,5-dimethylpyrazin-2-yl)-1-(4-methylphenyl)pyrazole-3-carbonyl]-1-(4-methylphenyl)-1,8-diazaspiro[4.5]decan-4-one;1-(4-methylphenyl)-8-[1-(4-methylphenyl)-5-pyridin-3-ylpyrazole-3-carbonyl]-1,8-diazaspiro[4.5]decan-4-one;bis(1-(4-methylphenyl)-8-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]-1,3,8-triazaspiro[4.5]decan-4-one);3-[1-(1-phenyl-5-pyridin-4-ylpyrazole-3-carbonyl)piperidin-4-yl]-1H-benzimidazol-2-one?
The InChIKey is GTBRNILHWFBMIZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C32H34N6O2.C31H31N5O2.2C30H27F3N6O2.C27H24N6O2/c1-21-5-9-25(10-6-21)37-16-13-29(39)32(37)14-17-36(18-15-32)31(40)27-19-28(30-24(4)34-23(3)20-33-30)38(35-27)26-11-7-22(2)8-12-26;1-22-5-9-25(10-6-22)35-17-13-29(37)31(35)14-18-34(19-15-31)30(38)27-20-28(24-4-3-16-32-21-24)36(33-27)26-11-7-23(2)8-12-26;2*1-20-2-6-23(7-3-20)38-19-35-28(41)29(38)12-16-37(17-13-29)27(40)25-18-26(21-10-14-34-15-11-21)39(36-25)24-8-4-22(5-9-24)30(31,32)33;34-26(31-16-12-20(13-17-31)32-24-9-5-4-8-22(24)29-27(32)35)23-18-25(19-10-14-28-15-11-19)33(30-23)21-6-2-1-3-7-21/h5-12,19-20H,13-18H2,1-4H3;3-12,16,20-21H,13-15,17-19H2,1-2H3;2*2-11,14-15,18H,12-13,16-17,19H2,1H3,(H,35,41);1-11,14-15,18,20H,12-13,16-17H2,(H,29,35).
What are the key properties of 8-[5-(3,5-dimethylpyrazin-2-yl)-1-(4-methylphenyl)pyrazole-3-carbonyl]-1-(4-methylphenyl)-1,8-diazaspiro[4.5]decan-4-one;1-(4-methylphenyl)-8-[1-(4-methylphenyl)-5-pyridin-3-ylpyrazole-3-carbonyl]-1,8-diazaspiro[4.5]decan-4-one;bis(1-(4-methylphenyl)-8-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]-1,3,8-triazaspiro[4.5]decan-4-one);3-[1-(1-phenyl-5-pyridin-4-ylpyrazole-3-carbonyl)piperidin-4-yl]-1H-benzimidazol-2-one?
8-[5-(3,5-dimethylpyrazin-2-yl)-1-(4-methylphenyl)pyrazole-3-carbonyl]-1-(4-methylphenyl)-1,8-diazaspiro[4.5]decan-4-one;1-(4-methylphenyl)-8-[1-(4-methylphenyl)-5-pyridin-3-ylpyrazole-3-carbonyl]-1,8-diazaspiro[4.5]decan-4-one;bis(1-(4-methylphenyl)-8-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]-1,3,8-triazaspiro[4.5]decan-4-one);3-[1-(1-phenyl-5-pyridin-4-ylpyrazole-3-carbonyl)piperidin-4-yl]-1H-benzimidazol-2-one has a molecular weight of 2625.97 g/mol, XLogP of 23.74, 20 rotatable bonds, 3 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for 8-[5-(3,5-dimethylpyrazin-2-yl)-1-(4-methylphenyl)pyrazole-3-carbonyl]-1-(4-methylphenyl)-1,8-diazaspiro[4.5]decan-4-one;1-(4-methylphenyl)-8-[1-(4-methylphenyl)-5-pyridin-3-ylpyrazole-3-carbonyl]-1,8-diazaspiro[4.5]decan-4-one;bis(1-(4-methylphenyl)-8-[5-pyridin-4-yl-1-[4-(trifluoromethyl)phenyl]pyrazole-3-carbonyl]-1,3,8-triazaspiro[4.5]decan-4-one);3-[1-(1-phenyl-5-pyridin-4-ylpyrazole-3-carbonyl)piperidin-4-yl]-1H-benzimidazol-2-one is sourced from PubChem (CID 158357669), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).